Asymchem to continue cash management with idle A-share funds

Asymchem Laboratories (Tianjin) announced on September 16, 2025, that its board of directors approved the continued use of up to CNY 60,000 million of temporarily idle A-share raised funds for cash management. These funds will be invested in principal-protected wealth management products for a period of up to 12 months from the board's approval. The initiative seeks to improve the efficiency of fund utilization and increase financial returns without affecting the company's investment projects or daily operations.

The company's independent financial advisor, First Capital Securities, confirmed that the proposed cash management plan complies with regulatory requirements and does not alter the intended use of the raised funds or harm the interests of the company and its shareholders. As of July 31, 2025, Asymchem had utilized CNY 1,655.6089 million of raised funds, generated CNY 66.3417 million in wealth management product income, and had CNY 697.6595 million remaining in its dedicated raised funds account.

The company will primarily invest in low-risk, highly liquid, and short-term principal-protected products from reputable financial institutions. The board has authorized management to execute investment decisions and relevant contracts within the approved limits, with the finance department overseeing the specific transactions. This strategy is expected to yield investment income, further enhancing the company's overall performance.